News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
139,344 Results
Type
Article (4720)
Company Profile (90)
Press Release (134534)
Section
Business (44668)
Career Advice (209)
Deals (6823)
Drug Delivery (13)
Drug Development (18400)
Employer Resources (19)
FDA (1709)
Job Trends (2891)
News (70773)
Policy (4078)
Tag
2024 BioCapital Digital (2)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (6)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 Biotech Bay Standard (1)
Academia (304)
Adcomms (1)
Allergies (15)
Alliances (12660)
ALS (27)
Alzheimer's disease (322)
Antibody-drug conjugate (ADC) (24)
Approvals (1717)
Artificial intelligence (45)
Autoimmune disease (6)
Automation (3)
Bankruptcy (38)
Best Places to Work (2336)
BIOSECURE Act (13)
Biosimilars (8)
Biotechnology (85)
Bladder cancer (19)
Brain cancer (6)
Breast cancer (66)
Cancer (520)
Cardiovascular disease (14)
Career advice (197)
Career pathing (4)
CAR-T (53)
Cell therapy (165)
Cervical cancer (5)
Clinical research (14874)
Collaboration (251)
Compensation (98)
Complete response letters (2)
COVID-19 (457)
CRISPR (7)
C-suite (94)
Cystic fibrosis (26)
Data (535)
Depression (6)
Diabetes (46)
Diagnostics (796)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (41)
Drug pricing (5)
Drug shortages (2)
Duchenne muscular dystrophy (20)
Earnings (13143)
Editorial (4)
Employer resources (19)
Events (25466)
Executive appointments (236)
FDA (1931)
Featured Employer (13)
Frontotemporal dementia (5)
Funding (213)
Gene editing (20)
Generative AI (4)
Gene therapy (77)
GLP-1 (112)
Government (363)
Guidances (8)
Healthcare (1787)
Huntington's disease (6)
IgA nephropathy (5)
Immunology and inflammation (23)
Indications (9)
Infectious disease (483)
Inflammatory bowel disease (49)
Inflation Reduction Act (1)
Influenza (16)
Intellectual property (34)
Interviews (18)
IPO (3105)
IRA (4)
Job creations (695)
Job search strategy (185)
Kidney cancer (1)
Labor market (7)
Layoffs (37)
Legal (764)
Liver cancer (13)
Lung cancer (38)
Lymphoma (44)
Management (5)
Manufacturing (79)
MASH (8)
Medical device (566)
Medtech (566)
Mergers & acquisitions (3901)
Metabolic disorders (108)
Multiple sclerosis (20)
NASH (1)
Neurodegenerative disease (15)
Neuropsychiatric disorders (3)
Neuroscience (434)
NextGen: Class of 2025 (891)
Non-profit (274)
Northern California (757)
Now hiring (4)
Obesity (57)
Opinion (37)
Ovarian cancer (28)
Pain (20)
Pancreatic cancer (19)
Parkinson's disease (33)
Partnered (4)
Patents (50)
Patient recruitment (26)
Peanut (11)
People (16891)
Pharmaceutical (10)
Phase I (5823)
Phase II (7061)
Phase III (3740)
Pipeline (267)
Podcasts (2)
Policy (23)
Postmarket research (249)
Preclinical (2470)
Press Release (51)
Prostate cancer (18)
Psychedelics (2)
Radiopharmaceuticals (50)
Rare diseases (68)
Real estate (1540)
Recruiting (10)
Regulatory (3247)
Reports (13)
Research institute (315)
Resumes & cover letters (20)
RSV (4)
Schizophrenia (12)
Series A (40)
Series B (28)
Service/supplier (3)
Sickle cell disease (10)
Southern California (680)
Special edition (1)
Spinal muscular atrophy (36)
Sponsored (4)
Startups (1045)
State (1)
Stomach cancer (2)
Supply chain (13)
The Weekly (2)
United States (5822)
Vaccines (75)
Venture capitalists (7)
Webinars (6)
Weight loss (20)
Women's health (4)
Worklife (2)
Date
Today (38)
Last 7 days (144)
Last 30 days (792)
Last 365 days (9232)
2025 (2070)
2024 (9486)
2023 (10278)
2022 (13453)
2021 (13957)
2020 (10817)
2019 (7295)
2018 (5660)
2017 (6599)
2016 (6019)
2015 (7050)
2014 (5393)
2013 (4438)
2012 (4849)
2011 (5270)
2010 (4845)
Location
Africa (139)
Alabama (27)
Alaska (1)
Arizona (25)
Arkansas (2)
Asia (8901)
Australia (2112)
California (1729)
Canada (524)
China (101)
Colorado (29)
Connecticut (62)
Delaware (22)
Europe (22398)
Florida (160)
Georgia (22)
Idaho (11)
Illinois (125)
India (3)
Indiana (89)
Iowa (1)
Japan (33)
Kansas (11)
Kentucky (2)
Louisiana (1)
Maine (2)
Maryland (205)
Massachusetts (1272)
Michigan (69)
Minnesota (88)
Missouri (7)
Montana (8)
Nebraska (2)
Nevada (4)
New Hampshire (5)
New Jersey (396)
New Mexico (6)
New York (428)
North Carolina (255)
North Dakota (3)
Northern California (757)
Ohio (37)
Oklahoma (5)
Oregon (4)
Pennsylvania (393)
Puerto Rico (3)
Rhode Island (4)
South America (213)
South Carolina (1)
Southern California (680)
Tennessee (15)
Texas (207)
Utah (22)
Virginia (10)
Washington D.C. (7)
Washington State (302)
Wisconsin (6)
139,344 Results for "immatics biotechnologies gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
March 19, 2025
·
1 min read
Press Releases
T-CURX GmbH Enters into Technology Access Agreement with Kytopen
February 14, 2025
·
5 min read
Collaboration
BMS’ Cost-Cutting Campaign Claims Collabs With Immatics, Century
Bristol Myers Squibb aims to generate around $1.5 billion in savings through 2025—a goal that it hopes to reach by lowering third-party expenditures, focusing only on key growth brands and cutting some 2,200 jobs by year-end.
December 16, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Immatics Announces Pricing of $150 Million Public Offering
October 11, 2024
·
3 min read
Press Releases
Immatics Announces Proposed $150 Million Public Offering
October 10, 2024
·
3 min read
Business
Immatics Announces First Quarter 2024 Financial Results and Business Update
Immatics N.V., a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, provided a business update and reported financial results for the quarter ended March 31, 2024.
May 14, 2024
·
20 min read
Press Releases
Swarm Oncology Ltd. and Cellex Cell Professionals GmbH Announce Strategic Partnership to Advance Swarm’s Innovative T Cell Therapies for Solid Cancers
February 25, 2025
·
3 min read
Business
Immatics Announces Full Year 2023 Financial Results and Corporate Update
Immatics N.V. provided a business update and reported financial results for the quarter and full year ended December 31, 2023.
March 21, 2024
·
19 min read
Press Releases
Immatics Appoints Alise Reicin to Board of Directors
July 31, 2024
·
5 min read
Lone Star Bio
Immatics Announces Pricing of $175 Million Public Offering
Immatics N.V. announced the pricing of an underwritten public offering of 15,925,000 ordinary shares at a public offering price of $11.00 per share.
January 17, 2024
·
3 min read
1 of 13,935
Next
